Clinical Trial Update: A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD) [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety, tolerability, and pharmacokinetics of UCB7853 in healthy participants and individuals with Parkinson's disease; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• UCB7853

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED